Purpose Unlimited Inc’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.6K Sell
519
-14
-3% -$2.1K ﹤0.01% 304
2026
Q1
$81.4K Sell
533
-61
-10% -$9.35K ﹤0.01% 299
2025
Q4
$81.9K Buy
+594
New +$77.8K ﹤0.01% 223

Other funds holding NVS

Purpose Unlimited Inc's NVS Position: Q2 2026 in Review

Purpose Unlimited Inc reduced its Novartis (NVS) stake by 2.6% in Q2 2026, selling an estimated $2.1K and leaving 519 shares worth $81.6K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Purpose Unlimited Inc first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $81.9K in Q4 2025. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Purpose Unlimited Inc held 519 shares of Novartis worth $81.6K as of Q2 2026.
  • Purpose Unlimited Inc sold 14 Novartis shares in Q2 2026, an estimated $2.1K.
  • Novartis made up ﹤0.01% of Purpose Unlimited Inc's portfolio in Q2 2026, its #304 holding.
  • Purpose Unlimited Inc first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • Purpose Unlimited Inc's Novartis position peaked at $81.9K in Q4 2025.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Purpose Unlimited Inc's 13F filing for Q2 2026, filed 13 Aug 2026.